Results 41 to 50 of about 352,577 (300)

Intraductal papillary neoplasm of the bile duct

World Journal of Gastroenterology, 2013
Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. IPNBs are mainly found in patients from Far Eastern areas, where hepatolithiasis and clonorchiasis are endemic.
Xue-Shuai, Wan, Yi-Yao, Xu, Jun-Yan, Qian, Xiao-Bo, Yang, An-Qiang, Wang, Lian, He, Hai-Tao, Zhao, Xin-Ting, Sang   +7 more
openaire   +2 more sources

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison   +2 more
wiley   +1 more source

Embryonal rhabdomyosarcoma of the biliary tree: A rare cause of obstructive jaundice in children which can mimic choledochal cysts

Indian Journal of Radiology and Imaging, 2017
Jaundice in children is more often due to hepatic disease than obstruction. Differential considerations for obstructive jaundice in children include choledocholithiasis, choledochal cysts and rare neoplasms.
Dhara J Kinariwala, Andrew Y Wang, Patrick D Melmer, William P McCullough   +3 more
doaj   +1 more source

Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology [PDF]

, 2017
Invasive biliary tract carcinomas are usually tubular adenocaricnomas with abundant desmoplastic reactions and frequent ductal and periductal invasion at the time of the diagnosis.
Uesaka, Katsuhiko, Yamaguchi, Hiroshi, Ohtsuka, Masayuki, Miyayama, Shiro, Nakanuma, Yasuni   +4 more
core   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

Extrahepatic Bile Duct Duplication with Intraductal Papillary Neoplasm: A Case Report

대한영상의학회지, 2021
Extrahepatic duct duplication is an extremely rare congenital anomaly. Hilar cholangiocarcinoma with extrahepatic bile duct duplication was reported; however, intraductal papillary neoplasm of the bile duct (IPNB) with extrahepatic bile duct ...
Gayoung Jeon, Juwan Choi
doaj   +1 more source

Intraductal papillary growth of liver metastasis originating from colon carcinoma in the bile duct: report of a case. [PDF]

, 2011
Morphologically, liver metastases from colorectal carcinoma usually form as nodular tumor masses, whereas intraductal papillary growth in the bile duct is rare.
Hiroaki Takeshita, Nanashima, Atsushi, Araki, Masato, Abe, Kuniko, Masato Araki, Atsushi Nanashima, Tohru Nakagoe, Harada, Kenichi, Kunizaki, Masaki, Takeshita, Hiroaki, Sawai, Terumitsu, Kuniko Abe, Nagayasu, Takeshi, Syuuichi Tobinaga, Hideyuki Hayashi, Terumitsu Sawai, Masaki Kunizaki, Yasuni Nakanuma, Hayashi, Hideyuki, Takeshi Nagayasu, Nakagoe, Tohru, Kenichi Harada, Tobinaga, Syuuichi, Nakanuma, Yasuni   +23 more
core   +1 more source

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

Hepatology, EarlyView., 2022
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, Shoichiro Tange, Daisuke Motooka, Yutaka Suzuki, Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Yoshihiro Ono, Yu Takahashi, Yota Kawasaki, Satoshi Iino, Shogo Kobayashi, Masashi Idogawa, Takashi Tokino, Tomomi Hashidate‐Yoshida, Hideo Shindou, Masanori Miyazaki, Yasuharu Imai, Satoshi Tanaka, Eiji Mita, Kazuyoshi Ohkawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Hidetoshi Eguchi, Eiichi Morii, Tetsuo Takehara   +29 more
wiley   +1 more source

Open Common Bile Duct Exploration in a Nigerian Tertiary Hospital [PDF]

, 2018
Background: The prevalence of extra-hepatic biliary stones in Nigeria is unknown and its treatment frequently undocumented. We have observed an increase in bile duct exploration in our hospital.
Olusegun Alatise, Lawal, Oladejo, Bolanle Ibitoye, Arowolo, Olukayode, Oladejo Lawal, Olukayode Arowolo,, Adisa, Adewale, Ibitoye, Bolanle, Olalekan Olasehinde, Olasehinde, Olalekan, Adewale Adisa, Alatise, Olusegun   +11 more
core   +1 more source

Proteogenomic characterization of cholangiocarcinoma

Hepatology, EarlyView., 2022
Proteogenomic characterization of cholangiocarcinoma with therapeutic strategies Abstract Background and Aims Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment ...
Mengjie Deng, Peng Ran, Lingli Chen, Yunzhi Wang, Zixiang Yu, Ke Cai, Jinwen Feng, Zhaoyu Qin, Yanan Yin, Subei Tan, Yang Liu, Chen Xu, Guoming Shi, Yuan Ji, Jian‐Yuan Zhao, Jian Zhou, Jia Fan, Yingyong Hou, Chen Ding   +18 more
wiley   +1 more source